Forbes

What if Pluribus were real? An Oxford neuroethicist, a physician-philosopher and a bioethicist weigh in on whether a human hive mind would save us or doom us.

Stocks of the biggest sellers of Obamacare were hit hard Tuesday after Vice President JD Vance said the Trump administration has yanked coverage of 750,000 due to fraud.

A one-time infusion of sugar-tagged bone marrow cells cut fragility fractures 94% in an osteoporosis trial, pointing toward a potential bone-regeneration treatment.

Concussion care has changed. Learn what current guidance says about rest, returning to school and sports, and helping teens recover.

“Hummer healthcare”—big, bulky, and historically inefficient—is bankrupting our nation. Other countries pay less and enjoy better health. We can and must do better

CTA Health Week convened experts to debate AI healthcare, humans in the loop and how close we are to democratizing these tools.

GLP-1 prescriptions are soaring for younger children despite the medications not being approved for this age group. Are they safe and effective in these children?

Data centers are expanding near more communities. Here’s what research says about potential health, environmental, quality-of-life risks and what still is not clear.

A recent GoodRx survey of a sample of Americans, conducted via YouGov, found that 26 percent of respondents reported at least one coverage gap in their health insurance.

President Donald Trump told White House OMB director, Russell Vought, to draft an executive order to create a board that would determine which grants the NIH would fund.

NHS hasn’t budgeted for the spending increase entailed by the U.S.-U.K. deal to allow payment for more drugs while keeping funding levels constant for other healthcare.

Sydney Sweeney demonstrated "sploshing' on an episode of the HBO Max series “Euphoria” aired earlier this year. Here's what this sex trend is and precautions to take.

The Trump administration has made bold claims about how much GLOBE and GUARD models will save Medicare. But most of those vanish once the exemptions are accounted for.

From AI-designed drugs to mammography, blood tests and trial matching, a physician describes seven ways AI could speed up cancer cures, and what 2026 data show.